✉ Email this page to a colleague
« Back to Dashboard
▶ Start for $1
Remove trial restrictions
Cefiderocol sulfate tosylateis the generic ingredient in one branded drug marketed by Shionogi Inc and is included in one NDA. There are three patents protecting this compound. Additional information is available in the individual branded drug profile pages.
Cefiderocol sulfate tosylate has seventy-nine patent family members in thirty-six countries.
One supplier is listed for this compound.
Summary for cefiderocol sulfate tosylate
Pharmacology for cefiderocol sulfate tosylate
|Drug Class||Cephalosporin Antibacterial |
Anatomical Therapeutic Chemical (ATC) Classes for cefiderocol sulfate tosylate
|Country||Patent Number||Title||Estimated Expiration|
|Taiwan||I535727||See Plans and Pricing|
|Mexico||2011004636||CEFAROSPORINAS QUE TIENEN UN GRUPO CATECOL. (CEPHALOSPORIN HAVING CATECHOL GROUP.)||See Plans and Pricing|
|Lithuania||PA2020530||See Plans and Pricing|
|South Korea||20110090982||CEPHALOSPORIN HAVING CATECHOL GROUP||See Plans and Pricing|
|San Marino||T201600397||CEFALOSPORINA AVENTE UN GRUPPO CATECOLO||See Plans and Pricing|
|Eurasian Patent Organization||201790522||СОЛЬ ПРОИЗВОДНОГО ЦЕФАЛОСПОРИНА, ЕЕ КРИСТАЛЛИЧЕСКОЕ ТВЕРДОЕ ВЕЩЕСТВО И СПОСОБ ЕЕ ПОЛУЧЕНИЯ||See Plans and Pricing|
|>Country||>Patent Number||>Title||>Estimated Expiration|
|Patent Number||Supplementary Protection Certificate||SPC Country||SPC Expiration||SPC Description|
|2960244||2020/044||Ireland||See Plans and Pricing||PRODUCT NAME: CEFIDEROCOL, OPTIONALLY IN THE FORM OF A PHARMACEUTICALLY ACCEPTABLE SALT OR SOLVATE; NAT REGISTRATION NO/DATE: EU/1/20/1434 20200424; FIRST REGISTRATION NO/DATE: EU/1/20/1434 20200424|
|2960244||2020C/541||Belgium||See Plans and Pricing||PRODUCT NAME: CEFIDEROCOL, OPTIONEEL IN DE VORM VAN EEN FARMACEUTISCH ZOUT OF SOLVAAT; AUTHORISATION NUMBER AND DATE: EU/1/20/1434 20200424|
|2960244||CA 2020 00049||Denmark||See Plans and Pricing||PRODUCT NAME: CEFIDEROCOL, EVENTUELT I FORM AF ET FARMACEUTISK ACCEPTABELT SALT ELLER SOLVAT; REG. NO/DATE: EU/1/20/1434 20200424|
|2960244||C202030051||Spain||See Plans and Pricing||PRODUCT NAME: CEFIDEROCOL, OPCIONALMENTE EN FORMA DE UNA SAL O SOLVATO FARMACEUTICAMENTE ACEPTABLE.; NATIONAL AUTHORISATION NUMBER: EU/1/20/1434; DATE OF AUTHORISATION: 20200423; NUMBER OF FIRST AUTHORISATION IN EUROPEAN ECONOMIC AREA (EEA): EU/1/20/1434; DATE OF FIRST AUTHORISATION IN EEA: 20200423|
|2960244||PA2020530||Lithuania||See Plans and Pricing||PRODUCT NAME: CEFIDEROKOLAS, PASIRINKTINAI FARMACISKAI PRIIMTINOS DRUSKOS ARBA SOLVATO PAVIDALU; REGISTRATION NO/DATE: EU/1/20/1434 20200423|
|2960244||43/2020||Austria||See Plans and Pricing||PRODUCT NAME: CEFIDEROCOL, GEGEBENENFALLS IN FORM EINES PHARMAZEUTISCH ANNEHMBAREN SALZES ODER SOLVATS; REGISTRATION NO/DATE: EU/1/20/1434 (MITTEILUNG) 20200424|
|>Patent Number||>Supplementary Protection Certificate||>SPC Country||>SPC Expiration||>SPC Description|
Make Better Decisions: Try a trial or see plans & pricing
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.